Lod, Israel

Ohad Mazor

This inventor holds 2 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 2011-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ohad Mazor. Retrieved from https://idiyas.com/inventor/ohad-mazor-7m65qfoh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0



Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ohad Mazor: Innovator in Bacteriochlorophyll Derivatives

Introduction

Ohad Mazor is a notable inventor based in Lod, Israel. He has made significant contributions to the field of photodynamic therapy through his innovative work on bacteriochlorophyll derivatives. With a total of 2 patents, his inventions are paving the way for advancements in medical diagnostics and treatments.

Latest Patents

Mazor's latest patents focus on water-soluble anionic bacteriochlorophyll derivatives and their uses. These inventions provide anionic water-soluble tetracyclic and pentacyclic bacteriochlorophyll derivatives (Bchls) that contain at least one, preferably two or three, negatively charged groups and/or acidic groups. These groups are converted to negatively charged groups at physiological pH, making them suitable for applications in photodynamic therapy and diagnosis.

Career Highlights

Ohad Mazor is associated with Yeda Research and Development Co. Ltd., where he continues to explore the potential of his inventions. His work is characterized by a commitment to enhancing therapeutic techniques through innovative chemical solutions.

Collaborations

Mazor has collaborated with esteemed colleagues such as Avigdor Scherz and Alexander Brandis. These partnerships have further enriched his research and development efforts in the field of bacteriochlorophyll derivatives.

Conclusion

Ohad Mazor's contributions to the field of bacteriochlorophyll derivatives exemplify the impact of innovation in medical science. His work not only advances therapeutic techniques but also highlights the importance of collaboration in research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…